max planck institut
informatik
mpii logo Minerva of the Max Planck Society

Geno2pheno [coreceptor] 2.0

New July 14th, 2011: European Guidelines have been implemented. Please note that on specific request of the "European Society for Antiviral Resistance" it is now mandatory to select a cutoff before doing the prediction.
New March 1st, 2011: geno2pheno[coreceptor] now allows for batch runs of up to 50 sequences. Just upload a fasta file containing the sequences and get the results in table- or csv-format. Furthermore we have adapted the alignment procedure to the one of geno2pheno[454]. Thus, it may happen that samples get prediction scores that differ from previous ones.
New April 20th, 2010: geno2pheno[coreceptor] is now also available for 454-data: http://g2p-454.bioinf.mpi-inf.mpg.de

On submitting a sequence containing the V3 region of the HIV-1 envelope protein gp120 below, you will obtain a sequence alignment to the reference strain HXB2 and a prediction whether the corresponding virus is capable of using CXCR4 as a coreceptor (R5/X4 or X4 variants) or not (R5 variants).

1. Identifier (optional)
Do not use patient names!
2. Significance Levels: Please select how conservative the detection of CXCR4 usage should be.

False positive rate is the probability of classifying an R5-virus falsely as X4.[Help]
Information on the German Treatment Guidelines, the Recommendations from the European Consensus Group
on clinical management of HIV-1 tropism testing
and on how to perform triplicate interpretations can be found here
3. Sequence containing the V3 region of gp120: upload from file (plain sequence or FASTA format)


4. Additional parameters
Viral load: Additional markers can help improving the predictions. Please use the nadir (ever lowest level) of
CD4-/CD8-cell counts and CD4 percentages.  [Help]
CCR5-genotype:
CD4 percentages:
CD4-cell counts:
CD8-cell counts:
5. Action:

You will make prediction № 375777. Service started June 1, 2004.